Pro Share Advisors LLC Puma Biotechnology, Inc. Transaction History

Pro Share Advisors LLC

  • $42.5 Billion
  • Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 11,853 shares of PBYI stock, worth $34,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,853
Holding current value
$34,136
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$2.42 - $3.39 $28,684 - $40,181
11,853 New
11,853 $36,000
Q2 2022

Aug 01, 2022
SELL
$1.64 - $3.3 $16,865 - $33,937
-10,284 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$2.13 - $3.24 $5,373 - $8,174
-2,523 Reduced 19.7%
10,284 $29,000
Q4 2021

Feb 08, 2022
SELL
$2.85 - $6.58 $105 - $243
-37 Reduced 0.29%
12,807 $39,000
Q3 2021

Nov 12, 2021
SELL
$6.63 - $9.39 $17,881 - $25,324
-2,697 Reduced 17.35%
12,844 $90,000
Q2 2021

Aug 13, 2021
BUY
$8.98 - $11.6 $15,948 - $20,601
1,776 Added 12.9%
15,541 $143,000
Q1 2021

May 14, 2021
BUY
$9.38 - $13.63 $7,494 - $10,890
799 Added 6.16%
13,765 $134,000
Q4 2020

Feb 09, 2021
BUY
$7.78 - $12.13 $22,017 - $34,327
2,830 Added 27.92%
12,966 $133,000
Q3 2020

Nov 13, 2020
SELL
$9.5 - $11.14 $2,907 - $3,408
-306 Reduced 2.93%
10,136 $102,000
Q2 2020

Aug 03, 2020
BUY
$7.01 - $13.24 $73,198 - $138,252
10,442 New
10,442 $109,000
Q1 2020

May 15, 2020
SELL
$6.28 - $14.57 $79,096 - $183,509
-12,595 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$6.5 - $10.73 $9,353 - $15,440
-1,439 Reduced 10.25%
12,595 $110,000
Q3 2019

Nov 12, 2019
SELL
$8.75 - $12.85 $2,852 - $4,189
-326 Reduced 2.27%
14,034 $151,000
Q2 2019

Aug 13, 2019
SELL
$12.3 - $35.76 $21,648 - $62,937
-1,760 Reduced 10.92%
14,360 $183,000
Q1 2019

May 15, 2019
BUY
$20.77 - $42.37 $2,658 - $5,423
128 Added 0.8%
16,120 $625,000
Q4 2018

Feb 14, 2019
SELL
$20.07 - $46.7 $61,755 - $143,695
-3,077 Reduced 16.14%
15,992 $325,000
Q3 2018

Nov 14, 2018
SELL
$41.2 - $59.85 $27,027 - $39,261
-656 Reduced 3.33%
19,069 $874,000
Q2 2018

Aug 13, 2018
SELL
$48.3 - $68.25 $65,398 - $92,410
-1,354 Reduced 6.42%
19,725 $1.17 Million
Q1 2018

May 14, 2018
SELL
$59.7 - $99.25 $203,338 - $338,045
-3,406 Reduced 13.91%
21,079 $1.43 Million
Q4 2017

Feb 14, 2018
BUY
$93.85 - $132.45 $2.11 Million - $2.98 Million
22,509 Added 1139.12%
24,485 $2.42 Million
Q3 2017

Nov 13, 2017
SELL
$72.0 - $119.75 $40,392 - $67,179
-561 Reduced 22.11%
1,976 $237,000
Q2 2017

Aug 11, 2017
BUY
N/A
2,537
2,537 $222,000

Others Institutions Holding PBYI

# of Institutions
110
Shares Held
28.3M
Call Options Held
27.9K
Put Options Held
3.4K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $131M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email